Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Variants in SARS-CoV-2 Associated with Mild or Severe Outcome

View ORCID ProfileJameson D. Voss, Martin Skarzynski, Erin M. McAuley, View ORCID ProfileEzekiel J. Maier, Thomas Gibbons, Anthony C. Fries, View ORCID ProfileRichard R. Chapleau
doi: https://doi.org/10.1101/2020.12.01.20242149
Jameson D. Voss
1US Air Force Medical Readiness Agency, Falls Church, VA 22042
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jameson D. Voss
  • For correspondence: jameson.d.voss.mil@mail.mil
Martin Skarzynski
2Booz Allen Hamilton, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin M. McAuley
2Booz Allen Hamilton, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ezekiel J. Maier
2Booz Allen Hamilton, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ezekiel J. Maier
Thomas Gibbons
3th, TX 78234
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony C. Fries
4US Air Force School of Aerospace Medicine, Wright Patterson AFB, OH 45433
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard R. Chapleau
4US Air Force School of Aerospace Medicine, Wright Patterson AFB, OH 45433
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard R. Chapleau
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction The coronavirus disease 2019 (COVID-19) pandemic is a global public health emergency causing a disparate burden of death and disability around the world. The molecular characteristics of the virus that predict better or worse outcome are largely still being discovered.

Methods We downloaded 155,958 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from GISAID and evaluated whether variants improved prediction of reported severity beyond age and region. We also evaluated specific variants to determine the magnitude of association with severity and the frequency of these variants among the genomes.

Results Logistic regression models that included viral genomic variants outperformed other models (AUC=0.91 as compared with 0.68 for age and gender alone; p<0.001). Among individual variants, we found 17 single nucleotide variants in SARS-CoV-2 have more than two-fold greater odds of being associated with higher severity and 67 variants associated with ≤ 0.5 times the odds of severity. The median frequency of associated variants was 0.15% (interquartile range 0.09%-0.45%). Altogether 85% of genomes had at least one variant associated with patient outcome.

Conclusion Numerous SARS-CoV-2 variants have two-fold or greater association with odds of mild or severe outcome and collectively, these variants are common. In addition to comprehensive mitigation efforts, public health measures should be prioritized to control the more severe manifestations of COVID-19 and the transmission chains linked to these severe cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded/supported by the United States Air Force, Air Force Research Laboratory, 711 HPW, Wright Patterson, AFB. Contract Support was provided by Booz Allen Hamilton.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A -- public data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available from GISAID. The shell scripts used for variant alignment and variant calling, along with the Python scripts used to perform the steps described in the manuscript should be accessed on GitHub at https://github.com/mskar/variants

https://www.gisaid.org/

https://github.com/mskar/variants

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted December 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Variants in SARS-CoV-2 Associated with Mild or Severe Outcome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Variants in SARS-CoV-2 Associated with Mild or Severe Outcome
Jameson D. Voss, Martin Skarzynski, Erin M. McAuley, Ezekiel J. Maier, Thomas Gibbons, Anthony C. Fries, Richard R. Chapleau
medRxiv 2020.12.01.20242149; doi: https://doi.org/10.1101/2020.12.01.20242149
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Variants in SARS-CoV-2 Associated with Mild or Severe Outcome
Jameson D. Voss, Martin Skarzynski, Erin M. McAuley, Ezekiel J. Maier, Thomas Gibbons, Anthony C. Fries, Richard R. Chapleau
medRxiv 2020.12.01.20242149; doi: https://doi.org/10.1101/2020.12.01.20242149

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4834)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)